Cervical Cancer Screening Frequency PDF
Defines reimbursement policy and recommended screening intervals for routine cervical cancer screening in average-risk women, excluding women with prior abnormal results, pre-cancerous lesions, cervical cancer, or immunocompromised status. Specifies age-based coverage and frequency limits.
Routine screening frequency for women age 21 to 65 will be reimbursed no more frequently than once every three years.
Routine screening pap testing will not be reimbursed for women younger than 21 years of age.
Reimbursement for routine pap testing for women 66 and older with prior negative screening results will be denied.
Coverage Summary
This policy defines reimbursement and recommended screening intervals for routine cervical cancer screening in average-risk women (those without prior abnormal results, pre-cancerous cervical lesions, cervical cancer, or immunocompromised status). It specifies age-based coverage and frequency limits for routine screening.
The purpose is to align reimbursement with major medical society guidelines and to set age-based frequency limits for routine Pap and HPV testing for average-risk women.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.